Rollins School of Public Health | Faculty Profile
Emory Rollins School of Public Health
Return to Faculty Listing

Allison  Brown

Adjunct Assistant Professor

Adjunct or Visiting, Epidemiology

Allison Brown, PhD, MPH, is the Associate Director of the Office of Laboratory Strategies and Analytics (OLSA) in the Division of Healthcare Quality Promotion at CDC. Dr. Brown’s team leads CDC’s Antibiotic Resistance Laboratory Network activities focused on detection and characterization of novel resistance in healthcare-associated infections. OLSA strategizes the deployment and implementation of laboratory and reporting capacities to and among domestic and international partners, as well as the use of testing results to inform AR containment activities. Dr. Brown was previously senior epidemiologist and Deputy Team Lead for the National Antimicrobial Resistance Monitoring System, focusing on the surveillance and epidemiology of antimicrobial resistant enteric infections. Prior to her work at CDC, Dr. Brown served as an Epidemic Intelligence Service Officer, working domestically and internationally on foodborne and waterborne diseases. She earned her PhD in Molecular Microbiology and Immunology from The Johns Hopkins Bloomberg School of Public Health, an MPH in Epidemiology of Microbial Diseases from Yale, and a BA in Biology from the University of Virginia.


Contact Information

Atlanta , GA


Update Profile

Areas of Interest

  • Antibiotic Resistance
  • Disease Surveillance
  • Public Health Informatics


  • Ph.D. 2010, The Johns Hopkins University
  • MPH 2004, Yale University

Affiliations & Activities

Full publication list:

Allison Brown | LinkedIn


  • , , Infectious period of SARS-CoV-2 in 17 nursing home residents — Arkansas, June–August 2020 , OFID, ,
  • , , Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales, J Antimicrob Chemother, ,
  • , , Antibiotic Resistance Threats in the United States, 2019. CDC, , ,
  • , , Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018, Antimicrob Agents Chemother, ,
  • , , Evaluation of the impact of antimicrobial hand towels on hand contamination with Escherichia coli among mothers in Kisumu County, Kenya, 2011-2012. Water Research, , ,
  • , , Notes from the Field: Verona Integron-Encoded Metallo-?-Lactamase–Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections in U.S. Residents Associated with Invasive Medical Procedures in Mexico, 2015–2018, MMWR, ,
  • , , Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017 , MMWR, ,
  • , , CTX-M-65 Extended-Spectrum ?-Lactamase–Producing Salmonella enterica Serotype Infantis, United States Nov 2018. EID. , , ,
  • , , Epidemiology of Salmonella enterica Serotype Dublin Infections among Humans, United States, 1968–2013, , ,
  • , , Risk factors for Acanthamoeba keratitis—a multi-state case-control study, 2008–2011 Eye and Contact Lens. , , ,
  • , , Antimicrobial resistance in Salmonella that caused foodborne disease outbreaks: United States, 2003–2012 , Epidemiology & Infection, ,
  • , , Immediate Closures and Violations Identified During Routine Inspections of Public Aquatic Facilities — Network for Aquatic Facility Inspection Surveillance, Five States, 2013., , ,
  • , , A Cluster Randomized Controlled Evaluation of the Health Impact of a Novel Antimicrobial Hand Towel on the Health of Children Under 2 Years Old in Rural Communities in Nyanza Province, Kenya , ASTMH, ,
  • , , Identification and Characterization of Multi-drug Resistant Salmonella Enterica Serotype Albert , Antimicrobial Agents and Chemotherapy, ,
  • , , Clinical characteristics of Acanthamoeba keratitis infections in 28 states, 2008 to 2011 , Cornea, ,